High-affinity [3H] kainic acid binding to brain membranes: A re- evaluation of ligand potency and selectivity

Journal of Pharmacological and Toxicological Methods

Volumn 42, Issue 3, 1999, Pages 121-125

  Crawford, Nicola ^a   Lang, Tracey K ^a   Kerr, D Steven ^a   De Vries, David J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Domoic acid; In vitro assay; Kainic acid; Radioligand binding

Indexed keywords

6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANIRACETAM; ASPARTIC ACID; CYCLOTHIAZIDE; CYSTEINE; DIZOCILPINE; DOMOIC ACID; GLUTAMIC ACID; GLUTAMINE; KAINIC ACID; QUINOLINIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION CONSTANT; DRUG BRAIN LEVEL; DRUG POTENCY; DRUG SELECTIVITY; MALE; MEMBRANE BINDING; NONHUMAN; RAT; ANIMAL; BINDING COMPETITION; BRAIN CORTEX; CELL MEMBRANE; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; GLUTAMINE; KAINIC ACID; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; TRITIUM;

EID: 0033237379     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00040-X     Document Type: Article

References (25)

1. Bleakman D., Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 37:1998;1187-1204.
2. Chang K.J., Jacobs S., Cuatrecasas P. Quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labelled and unlabelled hormones Biochim Biophys Acta. 406:1975;294-303.
3. Cheng Y.C., Prusoff W.H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 22:1973;3099-3108.
4. de Vries D.J., Herald C.L., Pettit G.R., Blumberg P.M. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain. Biochem Pharmacol. 37:1988;4069-4073.
5. Goldstein A., Barrett R.W. Ligand dissociation constants from competition binding assays. Errors associated with ligand depletion Mol Pharmacol. 31:1987;603-609.
6. Hampson D.R., Huang X.P., Wells J.W., Walter J.A., Wright J.L. Interaction of domoic acid and several derivatives with kainic acid and AMPA binding sites in rat brain. Eur J Pharmacol. 218:1992;1-8.
7. Hollman M., Heinemann S. Cloned glutamate receptors. Ann Rev Neurosci. 17:1994;31-108.
8. Huettner J.E. Glutamate receptor channels in rat DRG neurons. activation by kainate and quisqualate and blockade of desensitization by Con A Neuron. 5:1990;255-266.
9. 3H]kainate binding. Eur J Pharmacol. 246:1993;195-204.
10. Jorgensen M., Tygesen C.K., Andersen P.H. Inotropic glutamate receptors - focus on non-NMDA receptors. Pharmacol Toxicol. 76:1995;312-319.
11. 3H]Kainic acid to receptor sites in rat brain. Mol Pharmacol. 15:1979;492-505.
12. McPherson G.A. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC J Pharmacol Methods. 14:1985;213-228.
13. Munson P.J., Rodbard D. Ligand. A versatile computerized approach for characterization of ligand-binding systems Anal Biochem. 107:1980;220-239.
14. Ryan M., Beart P.M., de Vries D.J. Extracts of marine biota with bioactivity at glutamate receptor subtypes. Pharmacol Comm. 3:1993;225-232.
15. 3H]Kainic acid, an analogue of L-glutamate, to brain membranes. J Neurochem. 26:1976;141-147.
16. 3H]Kainic acid. Brain Res. 265:1983;169-172.
17. 3H]-AMPA to rat brain synaptic plasma membranes. Br J Pharmacol. 105:1992;83-86.
18. Sommer B., Burnashev N., Verdoorn T.A., Keinanen K., Sakamann B., Seeburg P.H. A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11:1992;1651-1656.
19. Tasker A., Strain S.M. Morphine differentially affects domoic acid and kainic acid toxicity in vivo. Neuroreport. 3:1992;789-792.
20. Tasker R.A., Connell B.J., Strain S.M. Pharmacology of systemically administered domoic acid in mice. Can J Physiol Pharmacol. 69:1991;378-382.
21. Tasker R.A., Strain S.M., Drejer J. Selective reduction in domoic acid toxicity in vivo by a novel non-N-methyl-D-aspartate receptor antagonist. Can J Physiol Pharmacol. 74:1996;1047-1054.
22. Teitelbaum J.S., Zatorre R.J., Carpenter S., Gendron D., Evans A.C., Gjedde A., Cashman N.R. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med. 322:1990;1781-1787.
23. 3H]-(2S,4R)-4-methylglutamate. pharmacological characterization in rabbit brain membranes Neuropharmacol. 36:1997;1483-1488.
24. Xi D., Ramsdell J.S. Glutamate receptors and calcium entry mechanisms for domoic acid in hippocampal neurons. Neuroreport. 7:1996;1115-1120.
25. Zhou L.M., Gu Z.Q., Costa A.M., Yamada K.A., Mansson P.E., Giordano T., Skolnick P., Jones K.A. 2S,4R)-4-methylglutamic acid (SYM 2081). a selective, high-affinity ligand for kainate receptors J Pharmacol Exp Ther. 280:1997;422-427.